Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 202833
Company: LEO LABS
Company: LEO LABS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PICATO | INGENOL MEBUTATE | 0.015% | GEL;TOPICAL | Discontinued | None | Yes | No |
PICATO | INGENOL MEBUTATE | 0.05% | GEL;TOPICAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/23/2012 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202833lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202833s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202833Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/19/2021 | SUPPL-13 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202833s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/202833Orig1s013ltr.pdf | |
12/17/2020 | SUPPL-12 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/202833Orig1s012ltr.pdf | |
02/13/2020 | SUPPL-11 | Labeling-Patient Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/202833Orig1s011ltr.pdf | |
01/26/2017 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/13/2016 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202833s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/202833Orig1s007ltr.pdf | |
04/15/2016 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |
||
10/06/2015 | SUPPL-5 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202833s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202833Orig1s005ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/202833Orig1s005.pdf | |
11/19/2015 | SUPPL-4 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202833s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202833Orig1s004ltr.pdf | |
02/03/2015 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/12/2014 | SUPPL-2 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202833Orig1s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202833Orig1s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
03/19/2021 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202833s013lbl.pdf | |
03/19/2021 | SUPPL-13 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202833s013lbl.pdf | |
12/17/2020 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s012lbl.pdf | |
12/17/2020 | SUPPL-12 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s012lbl.pdf | |
02/13/2020 | SUPPL-11 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s011lbl.pdf | |
02/13/2020 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202833s011lbl.pdf | |
09/13/2016 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202833s007lbl.pdf | |
11/19/2015 | SUPPL-4 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202833s004lbl.pdf | |
10/06/2015 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202833s005lbl.pdf | |
10/06/2015 | SUPPL-5 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202833s005lbl.pdf | |
03/12/2014 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202833Orig1s002lbl.pdf | |
01/23/2012 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202833lbl.pdf |